Heartworm Treatment Market Estimated to Soar Higher During 2018 to 2028
Heartworm disease is generally found in pets including cats and dogs which could be fatal in severe conditions. The pets are affected by the heartworm disease due to mosquitoes that carry heartworm larvae. It may cause several health issues, making heartworm treatment highly crucial which cannot be ignored. Rise in adoption of pets along with growing awareness of such diseases is expected to increase the adoption of heartworm treatment measures. The market for heartworm treatment is projected to witness a significant growth in the coming years with rising demand for animal welfare and increasing incidence of fatal disease in pets.
Growing awareness about veterinary healthcare along with enforcement of stringent regulations to prevent animal diseases are expected to be the key factors driving heartworm treatment market. Heartworm treatment come in different forms which are available only by prescription from veterinarians. This has led to surge in the demand for pet health insurance which in turn is likely to boost growth of the heartworm treatment market. Although rising healthcare expenditure indicates a positive outlook of the heartworm treatment market, high-cost associated with the preventive measures may create hindrance in the growth of heartworm treatment market. Further, lack of awareness of the treatment in several regions will possibly confine the market growth.
Heartworm treatment deals with the prevention and treatment of heartworm diseases. The overall veterinary treatment market has been growing in the past few years, due to the increasing awareness towards veterinary healthcare. Heartworm disease is a severe, fatal disease, which is generally found in pets. Heartworm disease is usually caused by foot-long worms present in the lungs, heart, and associated blood vessels of affected pets. Heartworm disease causes severe heart failure, lung disease, and damage to other organs in the body. Heartworm disease affects pets like cats, dogs, and ferrets. In addition, these worms also live in other mammal species such as coyotes, wolves, sea lions, foxes, and others. Species like coyotes and foxes live in proximity to many urban areas, thus, they are considered as important carriers of the heartworm disease. Dogs are considered to be a natural host for heartworms. It has also been found that, heartworm disease in cats is very different from heartworm disease in dogs. Cats are a typical host for heartworms. The symptoms of heartworm disease include a mild persistent cough, fatigue after moderate activity, reluctance to exercise, weight loss, and decreased appetite. Heartworms are spread through the bites of mosquitos that carry the infective heartworm larvae. The larvae continue to mature in the dog’s heart and lungs. Dogs are usually treated with three injections, namely: melarsomine, doxycycline, and prednisone. The melarsomine injection kills the adult heartworms and reduces the chances of unwanted side effects. Moreover, a severe case of heartworm disease requires a surgery to remove the worms from the heart and vessels within the lungs.
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1024
Heartworm Treatment Market: Drivers and Restraints
The rising incidence of disease in animals and implementation of stringent regulations to prevent animal diseases are the factors driving the growth of the global heartworm treatment market. Furthermore, the increasing demand for pet health insurance and rising healthcare expenditure are further boosting the global heartworm treatment market. However, high treatment cost is expected to hamper the growth of the global heartworm treatment market.
Heartworm Treatment Market: Segmentation
Tentatively, the global heartworm treatment market is segmented on the basis of treatment, distribution channel, and geography.
Based on treatment, the global heartworm treatment market is segmented as:
- Prednisone Injections
- Doxycycline Injections
- Melarsomine Injections
Based on distribution channel, the global heartworm treatment market is segmented as:
- Veterinary Hospitals
- Veterinary Clinics
Have Any Query? Ask our Industry Experts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1024
Heartworm Treatment Market: Overview
The global market for heartworm treatment is expected to witness high growth over the forecast period. Cost-effective, long-acting drugs for heartworm treatment are expected to create attractive growth opportunities for the global heartworm treatment market over the forecast period. Based on medication, the global heartworm treatment market is segmented into prednisone injections, doxycycline injections, and melarsomine injections. Melarsomine injections are not recommended for use in cats. Melarsomine is a prescription drug which can be only obtained from a veterinarian. Monthly preventive medication prescribed by a veterinarian protects most owned pets from this disease. Based on distribution channel, the global heartworm treatment market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment is expected to gain maximum market share in the global heartworm treatment market.
Heartworm Treatment Market: Regional Outlook
Geographically, the global heartworm treatment market is segmented into, viz. North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to hold maximum market share in the heartworm treatment market, owing to established healthcare facilities and a rise in healthcare expenditure. The Asia Pacific heartworm treatment market is one of the fastest growing markets at the highest CAGR, due to the presence of lenient regulations. Furthermore, the increasing focus of pet owners towards animal health and safety has boosted the growth of the heartworm treatment market.
Heartworm Treatment Market: Key Players
Some of the key players operating in the global heartworm treatment market are Boehringer Ingelheim, Mylan N.V., AdvaCare Pharma, Pfizer Inc., Zoetis Services LLC, Bristol-Meyers Squibb Co, and others.